PAPNET Testing System
Overview
The PAPNET Testing System was a pioneering semi-automated, computer-assisted screening device developed by Neuromedical Systems. It utilized neural network technology and algorithmic image processing to re-examine conventional Papanicolaou (Pap) smear slides. The system’s primary purpose was to assist pathologists and cytotechnologists in identifying cellular abnormalities, particularly those that might have been missed during initial manual microscopic examination, thereby aiming to reduce false-negative rates in cervical cancer screening. Rather than providing a definitive diagnosis, the PAPNET system would scan slides, select, and record images of up to 128 potentially abnormal cells or clusters. These flagged images were then presented on a high-resolution video screen for review and assessment by trained human observers. It was initially approved by the FDA for use in quality control and as an adjunct in the rescreening of cervical Pap smears previously reported as negative.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Neural network technology for cell image analysis
- Algorithmic image processing for object identification
- Semi-automated screening of conventional Pap smears
- Selection and recording of up to 128 potentially abnormal cell images per slide
- High-resolution video screen for cytotechnologist review
- Aids in detecting cervical epithelial abnormalities (e.g., LGSIL, HGSIL, ASCUS, AGUS, squamous cell carcinoma, endocervical adenocarcinoma)
- Intended for rescreening previously negative Pap smears (quality control/adjunctive testing)
Use Cases
- Rescreening of conventional Pap smears for quality control
- Adjunctive testing in cervical cancer screening laboratories
- Detection of cervical epithelial abnormalities missed by manual screening
- Enhancing early detection of cervical cancer and pre-cancerous conditions
What Physicians Need to Know
When utilizing AI-assisted cervical screening systems like PAPNET, physicians should recognize their role as powerful adjuncts to traditional Pap smear analysis, significantly improving the detection of subtle abnormalities and reducing false negatives. It's crucial to remember that these systems are designed to assist human cytotechnologists and pathologists, who retain the ultimate diagnostic responsibility. Emphasize the importance of high-quality sample collection and preparation, as even advanced AI relies on well-prepared slides for optimal performance. Integrate AI-enhanced screening into a comprehensive cervical cancer prevention strategy, potentially alongside HPV testing, for a more robust risk assessment.
The original PAPNET system was designed to integrate with existing laboratory workflows for conventional Pap smears, processing standard Papanicolaou-stained glass slides. For contemporary AI-assisted cervical screening, integration typically involves digital pathology platforms that support whole slide imaging (WSI) and cloud-based AI analysis. Seamless integration with Laboratory Information Systems (LIS) is essential for efficient workflow management, patient data tracking, and result reporting. Future integrations could extend to Electronic Health Records (EHR) for comprehensive patient management and potentially with other diagnostic tools, such as HPV testing results, to provide a holistic view of cervical health.
Details
| Category | OB/GYN AI, Oncology AI, Pathology AI |
| Pricing | Discontinued/n/a — N/A |
| Deployment | Initially a centralized service where slides were sent for scanning, later an on-premise hardware system (PAPNET-on-Cyte) was developed. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Yes AI-estimated The PAPNET Testing System received Premarket Approval (PMA) from the FDA on November 8, 1995 (P940029). It was approved as a semi-automated test indicated to aid in the rescreening of cervical Papanicolaou (Pap) smears previously reported as negative, intended to detect cervical epithelial abnormalities missed on prior manual microscopic examination. |
| Integrations | |
| EHR | Not specified |
| Specialties | Obstetrics & Gynecology, Oncology, Pathology |
What the Web Says
The PAPNET Testing System was an automated, interactive instrument designed to re-screen conventional Pap smears to improve the detection of abnormal cervical cells. It utilized neural network technology to identify potentially abnormal cells, which were then reviewed by trained cytologists. Studies from the late 1990s indicated that PAPNET could identify a significant number of abnormal and false-negative smears that were missed by manual screening, thereby enhancing quality control in cervical cytology.
Overall: MixedStrengths
- Improved detection of abnormal cervical cells, including precancerous lesions, compared to manual screening.
- Reduced false-negative rates in Pap smear analysis.
- Identified abnormal glandular cells with high detection rates.
- Potentially valuable for quality control in laboratories.
- Could improve accuracy in labs that perform rushed or sloppy manual screenings.
- Utilized advanced neural network technology for cell selection.
Limitations
- More expensive than having a human technician recheck slides.
- Cost-effectiveness was debated, with some studies suggesting a high cost per detected case.
- Charges for PAPNET rechecking were often not covered by insurance or managed-care plans.
- Did not attempt to diagnose cell abnormalities itself, requiring human review.
- Could miss abnormal cells if the number of diagnostic cellular material on a slide was extremely low.
- Interobserver agreement among reviewers using PAPNET images to classify atypical smears was not always unanimous.
Based on reviews from: Los Angeles Times, PubMed, ResearchGate, American Journal of Clinical Pathology | Oxford Academic, CancerNetwork
Last updated: 2026-07-19
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate PAPNET Testing System
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for PAPNET Testing System.
Cervical Cancer, HPV, and Pap Test, Animation
